Head and Neck Cancer News & Features
Most retinoblastoma survivors do not have poorer psychosocial functioning compared with people without cancer.
Imaging Method Has Potential to Predict Effectiveness of Induction Chemotherapy in Patients With Head and Neck Cancer
Researchers identified a potential new way to predict which patients with head and neck cancer will benefit most from chemotherapy.
Presence of depression can have a significant impact on patient quality of life and treatment outcomes.
Diabetes patients treated with the drug less likely to develop oropharyngeal and nasopharyngeal cancers.
New research reaffirms the association between inflammatory response and the spread of oral cancer.
Head and Neck Cancer Clinical Trials
- Gay, Bisexual Men Report Higher Rates of Skin Cancer Than Heterosexual Men
- Clinical Trial Demonstrates Superior Results With Immunotherapy vs Chemotherapy for Lung Cancer
- Half-Match Donors May be the Perfect Match In Transplantation for Blood Cancers
- Initial Safety Report Finds Acceptable Safety With Ibrutinib for Asymptomatic, High-Risk CLL
- Older Patients with Hodgkin Lymphoma Benefit from Treatment with Brentuximab Vedotin
- Tumor Grade (Fact Sheet)
- Harms of Cigarette Smoking and Health Benefits of Quitting (Fact Sheet)
- Two-Drug Combination Shows Promise Against One Type of Pancreatic Cancer
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Nutrition counseling recommended to reduce malnutrition in oncology patients
- Investigational Therapy Efficiently Depletes Immune System-Suppressing Treg Cells
- Handling closed system device-incompatible chemotherapy agents
- Detecting Cancer While It Is Still Small Impacts Survival
- Antioxidants May Be Harmful in Patients With Melanoma
- Gene Therapy Doubles Survival in Recurrent Glioblastoma
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|